1. A Nonprofit Drug Development Model Is Part of the Antimicrobial Resistance (AMR) Solution. (7th October 2021) Authors: Piddock, Laura J V; Paccaud, Jean-Pierre; O'Brien, Seamus; Childs, Michelle; Malpani, Rohit; Balasegaram, Manica Journal: Clinical infectious diseases Issue: Volume 74:Number 10(2022) Page Start: 1866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants. (13th December 2021) Authors: Ciusa, Maria Laura; Marshall, Robert L; Ricci, Vito; Stone, Jack W; Piddock, Laura J V Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 3(2022) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addressing antimicrobial resistance in the UK and Europe. Issue 12 (December 2017) Authors: Wells, Victoria; Piddock, Laura J V Journal: Lancet infectious diseases Issue: Volume 17:Issue 12(2017:Dec.) Page Start: 1230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BSAC Vanguard Report Series: The future of drug development. (23rd November 2021) Authors: Piddock, Laura J V Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 3(2022) Page Start: 543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Discovery and development of new antibacterial drugs: learning from experience?. (9th February 2018) Authors: Jackson, Nicole; Czaplewski, Lloyd; Piddock, Laura J V Journal: Journal of antimicrobial chemotherapy Issue: Volume 73:Number 6(2018) Page Start: 1452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EnvR is a potent repressor of acrAB transcription in Salmonella. (29th October 2022) Authors: Blair, Jessica M A; Siasat, Pauline; McNeil, Helen E; Colclough, Abigail; Ricci, Vito; Lawler, Amelia J; Abdalaal, Hind; Buckner, Michelle M C; Baylay, Alison; Busby, Stephen J; Piddock, Laura J V Journal: Journal of antimicrobial chemotherapy Issue: Volume 78:Number 1(2023) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. European Antibiotic Awareness Day and access to antibiotics. (19th November 2012) Authors: Brown, Nicholas M; Piddock, Laura J V; Dryden, Matthew S Journal: BMJ Issue: Volume 345(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fluoroquinolone resistance: Overuse of fluoroquinolones in human and veterinary medicine can breed resistance. Issue 7165 (17th October 1998) Authors: Piddock, Laura J V Journal: BMJ Issue: Volume 317:Issue 7165(1998) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reflecting on the final report of the O'Neill Review on Antimicrobial Resistance. Issue 7 (July 2016) Authors: Piddock, Laura J V Journal: Lancet infectious diseases Issue: Volume 16:Issue 7(2016:Jul.) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. To the G20: incentivising antibacterial research and development. Issue 8 (August 2017) Authors: Årdal, Christine; Baraldi, Enrico; Ciabuschi, Francesco; Outterson, Kevin; Rex, John H; Piddock, Laura J V; Findlay, David Journal: Lancet infectious diseases Issue: Volume 17:Issue 8(2017:Aug.) Page Start: 799 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗